E. N. Semernin

E. N. Semernin

Auto-generated profile, based on publicly available information

E. N. Semernin

Almazov National Medical Research Centre

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2007 in Cell and Tissue Biology
Verified
Journal Article
Closed access
PDF file
ESE. V. Shlyakhto
E. V. Shlyakhto
LBL. A. Bokeria
L. A. Bokeria
MRM. G. Rybakova
M. G. Rybakova
ESE. N. Semernin
E. N. Semernin
GSG. V. Selivanova
G. V. Selivanova
AGA. Ya. Goodkova
A. Ya. Goodkova
For a comparative analysis of cytomorphological characteristics of hypertrophied interventricular septum (IVS), both patients different ages with severe courses of obstructive hypertrophic...

9 March 2018 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
APA. A. Poliakova
A. A. Poliakova
EBE. I. Baranova
E. I. Baranova
ESE. N. Semernin
E. N. Semernin
AKA. N. Krutikov
A. N. Krutikov
ОМО. В. Мельник
О. В. Мельник
AGA. Ya. Gudkova
A. Ya. Gudkova
ГЕНДЕРНЫЕ РАЗЛИЧИЯ КЛИНИЧЕСКОГО ТЕЧЕНИЯ И РЕМОДЕЛИРОВАНИЯ СЕРДЦА ПРИ ИДИОПАТИЧЕСКОЙ ГИПЕРТРОФИЧЕСКОЙ КАРДИОМИОПАТИИ В ПОЖИЛОМ ВОЗРАСТЕ

8 September 2020 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
TBT. G. Bezhanishvili
T. G. Bezhanishvili
AGA. Ya. Gudkova
A. Ya. Gudkova
VDV. G. Davydova
V. G. Davydova
SASofiya Andreeva
Sofiya Andreeva
AKA. N. Krutikov
A. N. Krutikov
ЕШЕ. В. Шляхто
Е. В. Шляхто
Aim. To analyze associations of interleukin-6 receptor gene ( IL6R ) polymorphism (rs2228145) with the clinical course characteristics of hypertrophic cardiomyopathy (HCM) in groups of patients with various cardiometabolic risk factors Material and methods. The sample consisted of 123 patients with HCM. The age of the included patients ranged from 18 to 91 years (59 [41; 66.5]), of whom 59 were men, 64 — women. Two age groups were identified: the first group included patients from 18 to 44 years old, the second — 45 years and older. The control group consisted of 200 people without cardiovascular diseases and other severe comorbidities. For genetic testing, DNA was isolated from peripheral blood lymphocytes. Genotyping of the IL6R gene polymorphism (rs2228145) was carried out by realtime polymerase chain reaction. Results. A significant prevalence of CC genotype of the IL6R gene polymorphism (rs2228145) was revealed in patients aged ³45 years compared with the control group, which occurred in 14,1% and 3,0% of cases, respectively (CC:AC+AA, odds ratio (OR), 0,885, 95% confidence interval (CI), 1,051-0,691, p=0,006), and insignificant prevalence of C allele in this group, which does not reach the level of significance (A:C, OR, 0,870, 95% CI, 0,427-1,02, p=0,06). The prevalence of CC genotype (15,1% vs 3,0%) and C allele (39,0% vs 29,0%) was revealed in patients with HCM in combination with hypertension (HTN) compared with the control group (CC:AS+AA, OR=0,174, 95% CI, 0,047-0,650), p=0,004); (A:C, OR=0,638, 95% CI, 0,406-1,002), p=0,05). Conclusion. The relationship between the IL6R gene polymorphism (rs2228145) and HTN in patients with HCM was confirmed. The presence of CC genotype and C allele of the rs2228145 IL6R gene polymorphism is significantly more common in patients with HCM with the disease onset ³45 years of age. The presence of CC genotype and C allele of the IL6R gene polymorphism (rs2228145) is associated with HTN in patients with HCM.

9 March 2018 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
ESE. V. Shlyakhto
E. V. Shlyakhto
APA. A. Poliakova
A. A. Poliakova
ESE. N. Semernin
E. N. Semernin
AKA. N. Krutikov
A. N. Krutikov
AОA. Е. Оksas
A. Е. Оksas
AGA. Ya. Gudkova
A. Ya. Gudkova
АКРОМЕГАЛИЧЕСКАЯ КАРДИОМИОПАТИЯ С ДИНАМИЧЕСКОЙ ОБСТРУКЦИЕЙ ВЫНОСЯЩЕГО ТРАКТА ЛЕВОГО ЖЕЛУДОЧКА

26 November 2019 in Russian Journal of Cardiology
Verified
Journal Article
Open access
APA. Poliakova
A. Poliakova
AKA. Krutikov
A. Krutikov
ESE. Semernin
E. Semernin
AKAnna Kostareva
Anna Kostareva
AGA. Gudkova
A. Gudkova

27 November 2021 in The Scientific Notes of the Pavlov University
Verified
Journal Article
Open access
PDF file
ASA. A. Streltsova
A. A. Streltsova
AGA. Ya. Gudkova
A. Ya. Gudkova
SPS. A. Pyko
S. A. Pyko
ESE. N. Semernin
E. N. Semernin
AKAnna Kostareva
Anna Kostareva
The objective of this study was to determine the association of polymorphic variants rs2305619 and rs3816527 of the PTX3 gene with clinical profile and outcomes in hypertrophic cardiomyopathy (HCM) patients.Methods and materials. The study population consisted of 153 patients ≥18 years old with a confirmed diagnosis of HCM. The control group included 200 healthy donors. Duration of follow-up was 11 years (2008–2019 yrs.). The study design included a new model for determining variants of the clinical profile and outcomes of HCM. Polymorphic variants rs2305619 and rs3816527 of the PTX3 gene were genotyped by polymerase chain reaction.Results. The mortality rate in patients ≥18 years old with 1, 2 and 3 adverse pathways of HCM progression was significantly higher, compared with those without adverse pathways (р<0.001). A combination of chronic heart failure (CHF) with midrange and reduced LVEF (<49 %) with 1, 2 and 3 adverse pathways in HCM patients occurred more frequently, compared with those who had CHF with preserved LVEF (≥50 %) (odds ratio (OR) = 0.168, 95 % confidence interval (CI) =0.068–0.412, р<0.001). The genetic testing showed no significant differences in genotype and allele frequencies of polymorphic variants rs2305619 and rs3816527 of the PTX3 gene in patients with HCM and control groups. It was found a tendency for increase in GG genotype frequency (p<0.068) and significant increase in G allele frequency of rs2305619 of the PTX3 gene in HCM patients ≥18 years old and CHF with mid-range and reduced LVEF (<49 %) (A:G, OR=0.521, 95 % CI=0.301–0.902, p<0.019). HCM patients (age – 63 [58; 75] years) and type 2 diabetes mellitus demonstrated high prevalence in AG and GG genotypes (p<0.008) and G allele frequencies of rs2305619 of the PTX3 gene (A:G, OR =1.952, 95 % CI=1.076–3.542, p<0.026).Conclusions. HCM progression along 1 and more adverse pathways in patients ≥18 years old has been characterized with adverse outcome. G allele of rs2305619 of the PTX3 gene is associated with CHF with mid-range and reduced LVEF (<49 %) in HCM patients ≥18 years old. The associations of G allele and AG and GG genotypes of rs2305619 of the PTX3 gene with diabetes type 2 are observed in elderly HCM patients.